AstraZeneca’s Lynparza gets EU nod as first-line ovarian cancer maintenance treatment
Lynparza can now be used in patients who are in response following chemotherapy for advanced BRCA-mutated ovarian cancer in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Roche wins Japan approval for personalised cancer drug Rozlytrek
Rozlytrek aims to treat people with a rare genetic anomaly, called NTRK fusions, that drive growth in a range of tumours found…
Agilent hosts third edition of Total Agilent Experience in India
In the event, Agilent showcased its latest analytical solutions and applications, featured experts as speakers and conducted…
At Cadila, they beat the heat with HappyShift
As a first in the pharma industry, Cadila Pharmaceuticals recently declared a summer break for its entire staff from May 22 to May…
Sanofi, Google to use data tech for innovations
Data sets will be used to improve the understanding of key diseases and extract patients’ insights and feedback
French healthcare…
Biocon board approves sale of branded formulations business to subsidiary
The company has fixed July 1, 2019, as the expected date of completion of the sale
Pfizer to buy Array Biopharma for $10.64 bn in cash
Array is Pfizer’s first major purchase under new Chief Executive Albert Bourla, who took on the role in January
Pfizer will buy…
ConcePTION awarded grant to conduct research on meds used for pre- and post-natal care
The project unites 88 organisations from 22 countries, including the European Medicines Agency, drug manufacturers, academia,…
Women scientists for women’s welfare
Two women scientists — Dr Renu Swarup, Secretary, Department of Biotechnology, Ministry of Science and Technology, and…
Laurus Labs finishes USFDA inspection of its API facilities in Visakhapatnam
“This was a regular surveillance audit by US FDA, and no data integrity issues were observed in the inspection,” the company…